BRPI0713736A2 - Derivados de tetralina e indano e emprego destes - Google Patents
Derivados de tetralina e indano e emprego destesInfo
- Publication number
- BRPI0713736A2 BRPI0713736A2 BRPI0713736-2A2A BRPI0713736A BRPI0713736A2 BR PI0713736 A2 BRPI0713736 A2 BR PI0713736A2 BR PI0713736 A BRPI0713736 A BR PI0713736A BR PI0713736 A2 BRPI0713736 A2 BR PI0713736A2
- Authority
- BR
- Brazil
- Prior art keywords
- tetraline
- indian
- derivatives
- indian derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81531206P | 2006-06-20 | 2006-06-20 | |
PCT/EP2007/055873 WO2007147771A2 (en) | 2006-06-20 | 2007-06-14 | Tetralin and indane derivatives and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0713736A2 true BRPI0713736A2 (pt) | 2014-11-18 |
Family
ID=38353164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0713736-2A2A BRPI0713736A2 (pt) | 2006-06-20 | 2007-06-14 | Derivados de tetralina e indano e emprego destes |
Country Status (11)
Country | Link |
---|---|
US (2) | US7671235B2 (pt) |
EP (1) | EP2035370A2 (pt) |
JP (1) | JP2009541252A (pt) |
KR (1) | KR101066306B1 (pt) |
CN (1) | CN101472884A (pt) |
AU (1) | AU2007263084A1 (pt) |
BR (1) | BRPI0713736A2 (pt) |
CA (1) | CA2653758A1 (pt) |
IL (1) | IL195477A0 (pt) |
MX (1) | MX2008015843A (pt) |
WO (1) | WO2007147771A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
CA2591937C (en) * | 2004-12-21 | 2013-08-06 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
RU2388748C2 (ru) * | 2004-12-21 | 2010-05-10 | Ф. Хоффманн-Ля Рош Аг | Производные тетралина и индана и их применения в качестве антагонистов 5-нт |
ES2404827T3 (es) * | 2008-12-18 | 2013-05-29 | F. Hoffmann-La Roche Ag | Procedimiento para la síntesis de derivados aminometil-tetralina |
CN103038233B (zh) * | 2010-05-07 | 2017-06-20 | 吉利德康涅狄格有限公司 | 吡啶酮和氮杂吡啶酮化合物及使用方法 |
CN102276492B (zh) * | 2010-06-08 | 2013-04-10 | 上海医药工业研究院 | 阿戈美拉汀中间体及其制备方法 |
US9365566B2 (en) | 2012-03-27 | 2016-06-14 | Takeda Pharmaceutical Company Limited | Cinnoline derivatives |
JO3377B1 (ar) | 2013-03-11 | 2019-03-13 | Takeda Pharmaceuticals Co | مشتقات بيريدينيل وبيريدينيل مندمج |
DK3436447T3 (da) | 2016-03-31 | 2021-09-13 | Takeda Pharmaceuticals Co | Isoquinolinyl-triazolon-komplekser |
WO2018064559A1 (en) * | 2016-09-30 | 2018-04-05 | Biotie Therapies, Inc. | Compositions and methods for treating alzheimer's disease and parkinson's disease |
AU2022288926A1 (en) | 2021-06-08 | 2023-10-19 | Atai Therapeutics Inc. | Dimethoxyphenylalkylamine activators of serotonin receptors |
WO2023129909A1 (en) * | 2021-12-27 | 2023-07-06 | ATAI Life Sciences AG | Aminotetraline activators of serotonin receptors |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
US5506192A (en) * | 1990-06-07 | 1996-04-09 | Sandoz Ltd. | Substituted phthalides and heterocyclic phthalides |
WO1992002514A1 (en) * | 1990-07-27 | 1992-02-20 | Chugai Seiyaku Kabushiki Kaisha | Novel benzopyran derivative |
US5401848A (en) | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
US5817693A (en) * | 1991-11-05 | 1998-10-06 | Cousins; Russell Donovan | Endothelin receptor antagonists |
ZA93436B (en) * | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
CA2142471A1 (en) * | 1992-08-17 | 1994-03-03 | Hiroshi Koga | Benzopyran and benzoxazine derivatives |
US5374643A (en) | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
US5739135A (en) * | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
US6150402A (en) * | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
MX9710260A (es) | 1995-06-30 | 1998-03-29 | Upjohn Co | Isocromanos 1, 6-disustituidos para el tratamiento de migrañas. |
US5663194A (en) * | 1995-07-25 | 1997-09-02 | Mewshaw; Richard E. | Chroman-2-ylmethylamino derivatives |
FR2746756B1 (fr) * | 1996-04-01 | 1998-06-12 | Matra Transport International | Dispositif de detection de passage d'un mobile, tolerant aux pannes |
US5935958A (en) * | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
ES2179353T3 (es) | 1996-07-01 | 2003-01-16 | Schering Corp | Antagonistas muscarinicos. |
WO1998007418A1 (en) * | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
US6559144B2 (en) * | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
ATE390404T1 (de) * | 1997-02-27 | 2008-04-15 | Takeda Pharmaceutical | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta |
TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6586475B1 (en) * | 1998-11-20 | 2003-07-01 | Takeda Chemical Industries, Ltd. | β-amyloid protein production/secretion inhibitors |
WO2000034262A1 (fr) * | 1998-12-04 | 2000-06-15 | Takeda Chemical Industries, Ltd. | Derives de benzofuranne, leur procede de preparation et leurs utilisations |
CN1680280A (zh) * | 2000-04-03 | 2005-10-12 | 武田药品工业株式会社 | 制备胺衍生物的方法 |
JP2004509066A (ja) | 2000-05-10 | 2004-03-25 | スミスクライン・ビーチャム・コーポレイション | 新規抗感染症薬 |
AR035858A1 (es) * | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
CA2461381A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
WO2003029239A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
AU2002365198A1 (en) | 2001-10-30 | 2003-07-30 | Smithkline Beecham Corporation | Novel anti-infectives |
AU2003248566A1 (en) | 2002-05-24 | 2003-12-12 | Smithkline Beecham Corporation | Novel anti-infectives |
BR0311952A (pt) | 2002-06-20 | 2005-04-19 | Biovitrum Ab | Novos compostos úteis para o tratamento de obesidade, diabetes tipo ii e distúrbios do snc |
JP4754821B2 (ja) * | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ii型糖尿病およびcns障害の治療に有用な新規化合物 |
US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
US20040162285A1 (en) * | 2002-11-01 | 2004-08-19 | Pratt John K. | Anti-infective agents |
US20050075331A1 (en) * | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
US7902203B2 (en) * | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
AU2003297235A1 (en) | 2002-12-17 | 2004-07-22 | Smithkline Beecham Corporation | Anti-infectives |
WO2005037223A2 (en) * | 2003-10-15 | 2005-04-28 | Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
JP2007527412A (ja) | 2003-10-24 | 2007-09-27 | エグゼリクシス, インコーポレイテッド | Taoキナーゼモジュレーターおよび使用方法 |
AU2005291542B2 (en) * | 2004-09-30 | 2010-11-04 | F. Hoffmann-La Roche Ag | Compositions and methods for treating cognitive disorders |
US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
CA2591937C (en) * | 2004-12-21 | 2013-08-06 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
-
2007
- 2007-06-14 EP EP07765411A patent/EP2035370A2/en not_active Withdrawn
- 2007-06-14 BR BRPI0713736-2A2A patent/BRPI0713736A2/pt not_active IP Right Cessation
- 2007-06-14 KR KR1020087030944A patent/KR101066306B1/ko not_active IP Right Cessation
- 2007-06-14 AU AU2007263084A patent/AU2007263084A1/en not_active Abandoned
- 2007-06-14 JP JP2009515836A patent/JP2009541252A/ja active Pending
- 2007-06-14 CN CNA2007800226839A patent/CN101472884A/zh active Pending
- 2007-06-14 WO PCT/EP2007/055873 patent/WO2007147771A2/en active Application Filing
- 2007-06-14 MX MX2008015843A patent/MX2008015843A/es not_active Application Discontinuation
- 2007-06-14 CA CA002653758A patent/CA2653758A1/en not_active Abandoned
- 2007-06-20 US US11/820,712 patent/US7671235B2/en not_active Expired - Fee Related
-
2008
- 2008-11-24 IL IL195477A patent/IL195477A0/en unknown
-
2010
- 2010-01-26 US US12/694,033 patent/US7981923B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2653758A1 (en) | 2007-12-27 |
US7671235B2 (en) | 2010-03-02 |
IL195477A0 (en) | 2009-09-01 |
US7981923B2 (en) | 2011-07-19 |
US20100130742A1 (en) | 2010-05-27 |
KR101066306B1 (ko) | 2011-09-20 |
US20080015256A1 (en) | 2008-01-17 |
EP2035370A2 (en) | 2009-03-18 |
CN101472884A (zh) | 2009-07-01 |
WO2007147771A3 (en) | 2008-04-17 |
AU2007263084A1 (en) | 2007-12-27 |
KR20090017621A (ko) | 2009-02-18 |
WO2007147771A2 (en) | 2007-12-27 |
JP2009541252A (ja) | 2009-11-26 |
MX2008015843A (es) | 2009-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0713736A2 (pt) | Derivados de tetralina e indano e emprego destes | |
NL301192I2 (nl) | Finerenon en zijn zouten, solvaten en solvaten van de zouten daarvan | |
ATE531720T1 (de) | Aza-benzofuranylverbindungen und anwendungsverfahren dafür | |
CR10815A (es) | Nuevos derivados de isoquinolina e isoquinolinona sustituidos | |
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
CR10562A (es) | Nuevos derivados de piridazina | |
FR20C1027I2 (fr) | Derives de tiglien-3-one | |
ES2402426T8 (es) | Sonda médica | |
DE602007010272D1 (de) | Parkhilfevorrichtung und parkhilfeverfahren | |
DE602007010981D1 (de) | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate | |
DOP2010000044A (es) | Derivado de oxopirazina y herbicida | |
ATE511509T1 (de) | Azaindolylverbindungen und anwendungsverfahren | |
BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
DK2081955T3 (da) | Metastinderivater og anvendelse deraf | |
ATE526567T1 (de) | Zusammensteller und zusammenstellungsverfahren | |
BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
DK2001556T3 (da) | Thioninium-forbindelser og anvendelse deraf | |
BRPI0817844A2 (pt) | Derivados de 3-alcóxi-1-fenilpirazol e pesticidas | |
BRPI0811870A2 (pt) | Tratamento e prevenção de influenza | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
DE602006004713D1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
FI20065834A0 (fi) | Iskulaite | |
CR10430A (es) | Aminothiazoles and their uses | |
BRPI0815373A2 (pt) | Derivados de ciclo-hexeno e o uso dos mesmos como fragrâncias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |